91 related articles for article (PubMed ID: 1659750)
1. [Resource-saving treatment of deep venous thrombosis with low molecular weight heparin--but is it good enough?].
Arnesen H
Tidsskr Nor Laegeforen; 1991 Nov; 111(27):3266-7. PubMed ID: 1659750
[No Abstract] [Full Text] [Related]
2. [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study].
Faivre R; Neuhart E; Kieffer Y; Bassand JP; Maurat JP
J Mal Vasc; 1987; 12 Suppl B():145-6. PubMed ID: 2834488
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook].
Fiessinger JN
Bull Acad Natl Med; 1997 May; 181(5):875-83; discussion 883-5. PubMed ID: 9312362
[TBL] [Abstract][Full Text] [Related]
4. Treatment of deep venous thrombosis with low molecular weight heparins.
Ruiz F; Berman D
West J Med; 1998 Mar; 168(3):186-7. PubMed ID: 9549422
[No Abstract] [Full Text] [Related]
5. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.
van den Belt AG; Bossuyt PM; Prins MH; Gallus AS; Büller HR
Thromb Haemost; 1998 Feb; 79(2):259-63. PubMed ID: 9493572
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of deep venous thrombosis with low molecular weight heparin (Fragmin)].
Nesvold A; Ly B; Abildgaard U; Stiris M
Tidsskr Nor Laegeforen; 1991 Nov; 111(27):3296-7. PubMed ID: 1659751
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.
Hirsh J
Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406
[No Abstract] [Full Text] [Related]
8. Low-molecular-weight heparin for the treatment of deep vein thrombosis.
Thompson-Ford JK
Pharmacotherapy; 1998; 18(4):748-58. PubMed ID: 9692649
[TBL] [Abstract][Full Text] [Related]
9. Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis?
Brewer D
J Fam Pract; 1998 Sep; 47(3):185-92. PubMed ID: 9752370
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the relative efficacy and safety of low-molecular-weight heparin and unfractionated heparin for the treatment of venous thrombosis.
Hirsh J
Semin Thromb Hemost; 1996; 22 Suppl 2():7-12; discussion 29-30. PubMed ID: 8946613
[No Abstract] [Full Text] [Related]
11. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
[No Abstract] [Full Text] [Related]
12. [Anticoagulant treatment in deep venous thrombosis].
Navarro JL
Sangre (Barc); 1993 Apr; 38(2):125-30. PubMed ID: 8390725
[No Abstract] [Full Text] [Related]
13. Axillary venous thrombosis (Paget-Schroetter syndrome): possible therapy by low-molecular weight heparin.
Svarc M; Zádník J; Krc I
Acta Univ Palacki Olomuc Fac Med; 1993; 136():29-31. PubMed ID: 7887196
[TBL] [Abstract][Full Text] [Related]
14. Prevention of deep vein thrombosis--use of the low molecular weight heparin enoxaparin.
Forbes CD
Br J Clin Pract; 1989 Nov; 43(11):396-400. PubMed ID: 2558702
[No Abstract] [Full Text] [Related]
15. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
[TBL] [Abstract][Full Text] [Related]
16. [Drug therapy of deep venous thrombosis].
Bounameaux H
Ther Umsch; 1996 Apr; 53(4):272-6. PubMed ID: 8658349
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
Raskob GE
Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of venous thromboembolic disease using low molecular weight CY216 heparin in patients with high risk of hemorrhage].
Prandoni P; Vigo M; Tropeano PF; Carletti E; Corbetti F; Antonello G; Cuppini S
Ann Ital Med Int; 1988; 3(3):213-9. PubMed ID: 2856354
[No Abstract] [Full Text] [Related]
19. An overview of clinical trials of low molecular weight heparin fractions.
Levine MN; Hirsh J
Acta Chir Scand Suppl; 1988; 543():73-9. PubMed ID: 2847461
[TBL] [Abstract][Full Text] [Related]
20. [Monitoring of heparin in the treatment of deep venous thrombosis. An obsolete question?].
Toulemonde F; Kher A
Ann Cardiol Angeiol (Paris); 1995 Mar; 44(3):151-9. PubMed ID: 7793854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
